TY  - JOUR
T1  - An Overview on Guillain–Barré Syndrome Diagnostic and Management Approach
A1  - Hamad B. Alotaibi
A1  - Abdullah I. Mirdad
A1  - Fahad M. Algharbi
A1  - Tharaa M. Alabidi
A1  - Omran S. Alharbi
A1  - Rakan A. Al-Siwar
A1  - Mohammed M. Al-Salem
A1  - Khalid H. M. Alyami
A1  - Abdullah O. Alqasir
A1  - Abdulaziz A. Alharbi
JF  - International Journal of Pharmaceutical And Phytopharmacological Research
JO  - Int J Pharm Phytopharmacol Res
SN  - 2250-1029
Y1  - 2020
VL  - 10
IS  - 6
SP  - 138
EP  - 142
N2  - Background: Guillain Barré Syndrome (GBS) is a rare but life-threatening condition that can lead to demyelination of the peripheral nervous system. It has many subtypes, with different etiologies. It needs immediate intervention since if the intervention is delayed, it might lead to the death of patients or permanent disability. Treatment of acute cases is plasmapheresis or intravenous immunoglobulin. Objective: The objective of this review is to discuss Guillain–Barré Syndrome, different presentation, and management plan with the outcome. Method: We searched the PubMed database looking for relevant articles to the topic using Mesh terms, "Guillain–Barré Syndrome". Conclusion: Early detection and intervention can prevent mortality and morbidity in a major portion of patients with Guillain–Barré Syndrome.
UR  - https://eijppr.com/article/an-overview-on-guillainbarr-syndrome-diagnostic-and-management-approach
ER  -